Michelle A. Peluso - Feb 2, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Michelle A. Peluso
Stock symbol
CVS
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 03:32 PM
Previous filing
Sep 13, 2022
Next filing
Mar 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $0 +193K +1291.36% $0.00 207K Feb 2, 2023 Direct F1
holding CVS Common Stock (restricted) 82.6K Feb 2, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 86.4K Feb 2, 2023 Common Stock 86.4K $74.30 Direct F3
holding CVS Stock Option 57.2K Feb 2, 2023 Common Stock 57.2K $101.09 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 26, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 2, 2023.
F2 Consists of Restricted Stock Unit awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 02/26/2022.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F4 Option becomes exercisable in four equal annual installments, commencing 4/1/2023.